An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some experts stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer laws, risking penalties, prosecution or prison.
Platform Response and Material Removal
Based on TikTok, the platform has removed violative content and prohibited related keywords and query recommendations. The organization stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Research also discovered communities with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.
After minutes of joining one community, a vendor posted contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or past usage.
Item Details and Costs
Inside these groups, messages display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has already encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially serious medical dangers”.
